Pancreatic Cancer Research

ResearcherUniversitätsmedizin GreifswaldNo recent work listed

Wolfram von Bernstorff

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5061893056. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 11

  1. CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice. Co-author DOI 10.3390/biomedicines11061517↗
  2. Non-thermal plasma-treated solution demonstrates antitumor activity against pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.1038/s41598-017-08560-3↗
  3. LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer. Last author DOI 10.1186/s13027-017-0139-4↗
  4. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model. Co-author DOI 10.18632/oncotarget.15019↗
  5. Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade. Last author DOI 10.1016/j.pan.2016.03.005↗
  6. TRAIL Promotes Tumor Growth in a Syngeneic Murine Orthotopic Pancreatic Cancer Model and Affects the Host Immune Response. Last author DOI 10.1097/mpa.0000000000000469↗
  7. Surgical trauma leads to a shorter survival in a murine orthotopic pancreatic cancer model. Co-author DOI 10.1159/000368226↗
  8. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer. Last author DOI 10.1016/j.pan.2013.06.010↗
  9. Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo. Last author DOI 10.1186/1471-2407-12-473↗
  10. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines. Co-author DOI 10.1159/000329413↗
  11. In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. Last author DOI 10.1186/1471-2407-11-40↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lars Ivo Partecke · 9 shared papers, 2011–2023 · strength 0.59
  2. Frank Ulrich Weiß · 8 shared papers, 2011–2017 · strength 0.33
  3. André Käding · 7 shared papers, 2011–2017 · strength 0.32
  4. Katharina Beyer · 4 shared papers, 2016–2017 · strength 0.25
  5. Sander Bekeschus · 2 shared papers, 2017–2023 · strength 0.24
  6. Maik Lenz · 1 shared paper, 2023 · strength 0.17
  7. Lea Miebach · 1 shared paper, 2023 · strength 0.17
  8. Stephan Kersting · 1 shared paper, 2023 · strength 0.17
  9. Aydar Khabipov · 1 shared paper, 2023 · strength 0.17
  10. Julia V. Mayerle · 4 shared papers, 2011–2017 · strength 0.15
  11. Wolfram Keßler · 2 shared papers, 2016–2017 · strength 0.11
  12. Pia Menges · 2 shared papers, 2015–2016 · strength 0.10
  13. Markus M. Lerch · 3 shared papers, 2011–2016 · strength 0.09
  14. Kim Rouven Liedtke · 1 shared paper, 2017 · strength 0.07
  15. Lars-Ivo Partecke · 1 shared paper, 2013 · strength 0.03
  16. A. Stier · 1 shared paper, 2011 · strength 0.02
  17. Ivo L Partecke · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.